EDMONTON, Sept. 27 /CNW/ - Isotechnika today announced that two principal
investigators involved in the Company's Phase 3 psoriasis trials have been
selected to give oral presentations during the 21st World Dermatology
Conference in Buenos Aires, Argentina.
